Clinical Trial Update: Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 7-day PPI-based standard triple therapy to 10-day bismuth quadruple therapy for Helicobacter pylori eradication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Helicobacter Pylori Infection, Family History of Stomach Cancer | Phase 3 | Status: COMPLETED